Understand Where Allogeneic Developers Need Support
As allogeneic developers work to reduce donor variability, improve manufacturing consistency, and build scalable sourcing strategies, the need for specialist expertise and technology has never been greater.
The 4th Donor Selection & Cell Source Summit offers solution providers a focused opportunity to engage with the teams responsible for donor strategy across development, manufacturing, quality, and supply chain functions.
Connect With Decision-Makers Responsible For:
Manufacturing & Technical Operations
Process Development & MSAT
Supply Chain & Procurement
Quality & Regulatory Affairs
Analytical Development
Translational Sciences
Cell Therapy Research & Development
Understand and Educate Them on Key Priorities:
- Reducing donor-driven variability
- Improving manufacturing performance
- Securing reliable donor supply
- Strengthening donor characterization
- Supporting commercial-scale manufacturing
- Building scalable allogeneic development strategies
Why Get Involved?
Position your expertise alongside the conversations shaping the future of donor selection and cell sourcing while building relationships with the organizations driving the next generation of allogeneic cell therapies.
Explore the Full Event Guide
- Discover donor selection strategies from Cellectis, Mesoblast, Atara Bio, and Caribou Bio to improve clinical outcomes
- Explore donor sourcing from cord blood, PBMCs, and iPSCs to benchmark strategies, and gain clarity on where the field is moving
- Review the full agenda, speakers, and sessions to align team priorities
- Identify valuable networking opportunities to maximize connections with peers and providers